Defining and predicting complete remission of type 2 diabetes: A short-term efficacy study of open gastric bypass

Obesity Facts

Volumn 6, Issue 2, 2013, Pages 176-184

  Yan, Hongtao ^a,b   Tang, Lijun ^a   Chen, Tao ^a   Kral, John G ^c   Jiang, Li ^d   Li, Yunming ^a,e   Hu, Ruidong ^a   Cui, Jiangfeng ^a   Li, Shi ^a   Tian, Fuzhou ^a  

^a CHENGDU MILITARY GENERAL HOSPITAL   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

^c SUNY DOWNSTATE MEDICAL CENTER   (United States)

^d Cardiac Care Unit of Cardiothoracic Surgery   (United States)

^e FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Diabetes; Gastric bypass; Obesity; Pancreatic function; Remission

Indexed keywords

C PEPTIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CHINESE; DIARRHEA; DIETARY INTAKE; DIGESTIVE TRACT PARAMETERS; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOTHESIS; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OPEN GASTRIC BYPASS; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PANCREATIC ENDOCRINE RESERVE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REMISSION; RETROSPECTIVE STUDY; ROUX Y ANASTOMOSIS; SEX DIFFERENCE; STOMACH BYPASS; TREATMENT OUTCOME; WOUND HEALING IMPAIRMENT; CONTROLLED STUDY; GLUCOSE METABOLISM; ROUX EN Y GASTRIC BYPASS;

ADULT; AGED; BLOOD GLUCOSE; BODY WEIGHT; C-REACTIVE PROTEIN; CHINA; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; GASTRIC BYPASS; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY; REMISSION INDUCTION; SEX FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84877288910     PISSN: 16624025     EISSN: 16624033     Source Type: Journal    
DOI: 10.1159/000351018     Document Type: Article

References (22)

1. Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, Shan Z, Liu J, Tian H, Ji Q, et al: Prevalence of diabetes among men and women in China. N Engl J Med 2010; 362: 1090-1101.
2. Mason EE, Ito C: Gastric bypass in obesity. Surg Clin North Am 1967; 47: 1345-1351.
3. Pories WJ, Swanson MS, MacDonald KG, Long SB, Morris PG, Brown BM, Barakat HA, deRamon RA, Israel G, Dolezal JM, et al: Who would have thought it? An operation proves to be the most effective therapy for adultonset diabetes mellitus. Ann Surg 1995; 222: 339-350; discussion 350-332.
4. Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, Hamad G, Eid GM, Mattar S, Ramanathan R, Barinas-Mitchel E, et al: Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 2003; 238: 467-484; discussion 484-465.
5. Cummings DE, Overduin J, Foster-Schubert KE: Gastric bypass for obesity: Mechanisms of weight loss and diabetes resolution. J Clin Endocrinol Metab 2004; 89: 2608-2615. (Pubitemid 38766339)
6. Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, Pothier CE, Thomas S, Abood B, Nissen SE, Bhatt DL: Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 2012; 366: 1567-1576.
7. Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Leccesi L, Nanni G, Pomp A, Castagneto M, Ghirlanda G, et al: Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 2012; 366: 1577-1585.
8. Dixon JB, Zimmet P, Alberti KG, Rubino F: Bariatric surgery: An IDF statement for obese type 2 diabetes. Diabet Med 2011; 28: 628-642.
9. Kral JG: Selection of patients for anti-obesity surgery. Int J Obes Relat Metab Disord 2001; 25(suppl 1):S107-112. (Pubitemid 32565170)
10. WHO Expert Consultation: Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363: 157-163.
11. Tang L, Chen T, Cui J, Shi L, Yan H, Li Y, Tian F: Short-term effects of gastric bypass surgery for the treatment of non-obese type 2 diabetes mellitus (in Chinese). Chin J Dig Surg 2011; 10: 214-216.
12. Potteiger JA, Jacobsen DJ, Donnelly JE: A comparison of methods for analyzing glucose and insulin areas under the curve following nine months of exercise in overweight adults. Int J Obes Relat Metab Disord 2002; 26: 87-89. (Pubitemid 34098674)
13. Endocrine Surgery Group, Gastrointestinal Surgery Group and General Surgery Group of the Surgery Branch, Chinese Medical Association, et al: Guidance of diabetes surgical experts in China (2010) (in Chinese). Chin J Pract Surg 2011; 31: 54-58.
14. Pories WJ, MacDonald KG Jr, Morgan EJ, Sinha MK, Dohm GL, Swanson MS, Barakat HA, Khazanie PG, Leggett-Frazier N, Long SD, et al: Surgical treatment of obesity and its effect on diabetes: 10-y follow-up. Am J Clin Nutr 1992; 55: 582S-585S.
15. Zervos EE, Agle SC, Warren AJ, Lang CG, Fitzgerald TL, Dar M, Rotondo MF, Pories WJ: Amelioration of insulin requirement in patients undergoing duodenal bypass for reasons other than obesity implicates foregut factors in the pathophysiology of type II diabetes. J Am Coll Surg 2010; 210: 564-572.
16. Nannipieri M, Mari A, Anselmino M, Baldi S, Barsotti E, Guarino D, Camastra S, Bellini R, Berta RD, Ferrannini E: The role of beta-cell function and insulin sensitivity in the remission of type 2 diabetes after gastric bypass surgery. J Clin Endocrinol Metab 2011; 96:E1372-1379.
17. Chinese Diabetes Society: Chinese Guidelines for Diabetes (2010) (in Chinese). Suzhou2010.
18. Tfayli H, Lee SJ, Bacha F, Arslanian S: One-hour plasma glucose concentration during the OGTT: What does it tell about beta-cell function relative to insulin sensitivity in overweight/obese children? Pediatr Diabetes 2011; 12: 572-579.
19. Festa A, Williams K, Hanley AJ, Haffner SM: Beta-cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes: Comparison of surrogate markers with first-phase insulin secretion from an intravenous glucose tolerance test. Diabetes 2008; 57: 1638-1644.
20. Ikeda Y, Suehiro T, Nakamura T, Kumon Y, Hashimoto K: Clinical significance of the insulin resistance index as assessed by homeostasis model assessment. Endocr J 2001; 48: 81-86. (Pubitemid 32230388)
21. Ballantyne GH, Wasielewski A, Saunders JK: The surgical treatment of type II diabetes mellitus: Changes in HOMA insulin resistance in the first year following laparoscopic Roux-en-Y gastric bypass (LRYGB) and laparoscopic adjustable gastric banding (LAGB). Obes Surg 2009; 19: 1297-1303.
22. Wickremesekera K, Miller G, Naotunne TD, Knowles G, Stubbs RS: Loss of insulin resistance after Roux-en-Y gastric bypass surgery: A time course study. Obes Surg 2005; 15: 474-481. (Pubitemid 40605068)